American Academy of Pediatrics. (2021). Clinical Report: Genetic Metabolic Disorders. Pediatrics, 148(3), e2021053741.
[2]
Blom, W., & van Rijn, M. (2020). Inborn Errors of Metabolism with Branched-Chain Amino Acids. In: Saudubray JM, et al. (eds). Inborn Metabolic Diseases. Springer, Berlin.
[3]
Häberle, J., et al. (2019). Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. Journal of Inherited Metabolic Disease, 42(6), 1192-1230.
[4]
Kölker, S., et al. (2020). Current best practice in the management of methylmalonic and propionic acidemia. Molecular Genetics and Metabolism, 131(1-2), 23-30.
[5]
Nagao, K., et al. (2021). Branched-Chain Amino Acid Metabolism Disorders. In: NORD Guide to Rare Disorders. National Organization for Rare Disorders.
[6]
Saudubray, J.M., & Garcia-Cazorla, A. (2022). Inborn Errors of Metabolism in Children. In: Swaiman's Pediatric Neurology (6th ed.). Elsevier.
[7]
Wajner, M., & Latini, A. (2020). Branched-Chain Amino Acids and Neurodegeneration. Neurochemistry International, 138, 104782.
[8]
World Health Organization. (2022). International Classification of Diseases (ICD-10) Reference Guide. WHO, Geneva.
[9]
Zeltner, N.A., et al. (2021). Emergency Treatment in Inborn Errors of Metabolism. Journal of Inherited Metabolic Disease, 44(2), 290-307.
[10]
Zurflieh, M.R., et al. (2020). Diagnosis and Management of Maple Syrup Urine Disease: A Review. Molecular Genetics and Metabolism Reports, 25, 100674.